Investigational ALS Drug May Have Clinical Benefit, FDA Staff Says

[MEDPAGE TODAY]( Daily Headlines Monday, March 20, 2023 Today's Top Stories for {NAME} [NEUROLOGY]( [Investigational ALS Drug May Have Clinical Benefit, FDA Staff Says]( [INFECTIOUS DISEASE]( [Cases of Deadly Fungus Tripled in Past Few Years, CDC Says]( [PRIMARY CARE]( [Small Gains in Cardiorespiratory Fitness Track With Improved Longevity]( THE BREAK ROOM [Wordectomy: Guess Today’s Medical Condition]( CME SPOTLIGHT [Advancing Post-Transplant CMV Care: Diagnosis and First-Line Treatment]( [RADIOLOGY]( [Improved OS With Hyperfractionated RT in Recurrent Nasopharyngeal Carcinoma]( [SPECIAL REPORTS]( [GPT-4 Is Here. How Can Doctors Use Generative AI Now?]( THE BREAK ROOM [Play Today’s Wordosis]( ADVERTISEMENT [MEETING COVERAGE]( [Rapid Improvement in Atopic Dermatitis With Topical PDE4 Inhibitor]( CME SPOTLIGHT [Current Evidence and Guidelines for Treatment Selection for Relapsed/Refractory Multiple Myeloma]( [PULMONOLOGY]( [No Benefit to Conventional Ultrafiltration During Cardiac Surgery]( [GERIATRICS]( [Docs' Liking for Knee Injection Tied to Industry Payments]( [MEETING COVERAGE]( [New Approaches in the Bladder-Sparing Paradigm]( CME SPOTLIGHT [Evidence-Based Strategies for Integrating CAR T-Cell Therapy Into Non-Hodgkin Lymphoma Care]( [OPINION]( [Why Are Emergency Medicine Residents Disappearing?]( [OPINION]( [Primary Care Was the Loser in Our Residents' Popularity Contest ...]( [CASE STUDIES]( [Cases of Bald Spots After Regular Use of Detangling Hairbrushes]( CME SPOTLIGHT [Differentiating Established and Novel Treatment Approaches for TNBC Based on Mechanism of Action, Safety, Efficacy, and Approved Indications]( [NEUROLOGY]( [Post-Op Delirium Linked to Accelerated Cognitive Decline]( [MEETING COVERAGE]( [Response Rates in Hidradenitis Suppurativa Continue to Climb With New Therapies]( [PULMONOLOGY]( [Pulse Oximeters Confirmed to Be Biased for Black Kids]( CME SPOTLIGHT [Treatment and Management of Patients with HER2+ Advanced/Metastatic Breast Cancer]( [PRIMARY CARE]( [Old Diabetes Drug May Help Stave off Osteoarthritis]( [ASCO READING ROOM]( [Manish Kohli, MD, on Cost Effectiveness of Therapy for Metastatic Renal Cell Cancer]( [MEDICAL JOURNEYS]( [Melanoma: Palliative and End-of-Life Care]( [MEDICAL JOURNEYS]( [For Your Patients: Palliative Care]( # Weekly Survey [Give Paxlovid Full Approval?]( A panel of outside experts [recommended]( that the FDA grant full approval to nirmatrelvir-ritonavir (Paxlovid) for treating high-risk COVID[VOTE >]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Daily_DHE?xid=nl_mpt_DHE_2023-03-20&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011